“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for upcoming editions and more information from CITI Program.
HHS Restructures OCR to Better Handle Increased HIPAA Complaint Volume
Source: Health IT Security The HHS Office for Civil Rights (OCR) announced new restructuring efforts, including the formation of 3 new divisions, in order to better manage its increased volume of HIPAA and HITECH complaints.
Read The Full Article
How officials cracked case of eyedrops that blinded
Source: AP News The patients' eyes were painfully inflamed. They could sense light but could see almost nothing else. A doctor called one case the worst eye infection he’d ever seen.
Read The Full Article
Women, Black researchers less likely to hold multiple NIH grants
Source: Science Ranks of “super” principal investigators are growing, with white men dominating.
Read The Full Article
‘Unfair’ medical screening plagues polar research
Source: Science History of mental health treatment can be a disqualifier, interviews with Science reveal.
(Login may be required)
Read The Full Article
Twitter’s plan to cut off free data access evokes ‘fair amount of panic’ among scientists
Source: Science Social media platform’s intent to increase revenue could end or limit many research projects.
(Login may be required)
Read The Full Article
The Seven Deadly Sins of Biomedical Research
Source: Gerogetown Journal of International Affairs The risks of gain-of-function research on pandemic potential pathogens such as SARS and MERS outweigh the benefits.
Read The Full Article
Unlocking Midlevel Leaders’ Untapped Potential
Source: Inside Higher Ed The people in the middle are often the linchpins in changing campuses for the better, so we must expand our notions of who can lead and train them to do so, says Pamela L. Eddy.
(Login may be required)
Read The Full Article
My son’s time is running out due to a rare disease. The FDA needs to add more clinical trial flexibility
Source: STAT News It's time for @DrCaliff_FDA and the FDA to fundamentally reimagine how drugs for rare diseases are developed and remove needless obstacles that hinder clinical trials for them.
Read The Full Article
CRISPR patent fight redux? A new battle is brewing among biotechs over next-gen gene-editing tools
Source: STAT News The next CRISPR gene-editing patent war might look quite different; it's shaping up to be a free-for-all among a multitude of companies and labs.
(Login may be required)
Read The Full Article
